NEOS S&P 500 High Income ETF vs Twist Bioscience Corp — how do they compare? NEOS S&P 500 High Income ETF trades at $53.45, while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). Which is the better fit depends on your goals.
| SPYI | TWST | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $54.07 | $102.88 |
52-Week Low | $47.98 | $24.16 |
Market Cap | — | $5.45B |
Enterprise Value | — | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →